Cargando…
Local Sustained GM-CSF Delivery by Genetically Engineered Encapsulated Cells Enhanced Both Cellular and Humoral SARS-CoV-2 Spike-Specific Immune Response in an Experimental Murine Spike DNA Vaccination Model
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a worldwide pandemic with recurrences. Therefore, finding a vaccine for this virus became a priority for the scientific community. The SARS-CoV-2 spike protein has been described as the keystone for viral entry into cells and ef...
Autores principales: | Vernet, Rémi, Charrier, Emily, Cosset, Erika, Fièvre, Sabine, Tomasello, Ugo, Grogg, Julien, Mach, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151995/ https://www.ncbi.nlm.nih.gov/pubmed/34068677 http://dx.doi.org/10.3390/vaccines9050484 |
Ejemplares similares
-
A Quantitative ELISA Protocol for Detection of Specific Human IgG against the SARS-CoV-2 Spike Protein
por: Vernet, Rémi, et al.
Publicado: (2021) -
Possible inhibition of GM-CSF production by SARS-CoV-2 spike-based vaccines
por: Li, Jianhua, et al.
Publicado: (2021) -
Immortalized human myoblast cell lines for the delivery of therapeutic proteins using encapsulated cell technology
por: Lathuiliere, Aurelien, et al.
Publicado: (2022) -
Immortalized human myoblast cell lines for the delivery of therapeutic proteins using encapsulated cell technology
por: Lathuiliere, Aurelien, et al.
Publicado: (2023) -
GM-CSF in inflammation
por: Hamilton, John A.
Publicado: (2019)